Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Rithm Capital Corp. RITM

Alternate Symbol(s):  RITM.P.B

Rithm Capital Corp operates as a real estate investment trust that provides capital and services to the real estate and financial services industries. The company's mission is to generate attractive risk-adjusted returns in all interest rate environments through a complementary portfolio of investments and operating businesses. Rithm Capital's investment portfolio is composed of mortgage servicing related assets (full and excess MSRs and servicer advances), residential securities (and associated call rights) and loans (including single family rental), and consumer loans.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NYSE:RITM)

Fundamentals Snapshot (NYSE:RITM)

Opinion & Analysis (NYSE:RITM)

No current opinion is available.

Bullboard Posts (NYSE:RITM)

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

   
Eevhie - July 15, 2022

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

<< View Post To Watch Video >> FSD Pharma ready to proceed with Phase 2 clinical trial of FSD-201 as soon as it gets...
Eevhie - June 3, 2022

FSD Pharma Files Investigational New Drug Application “IND”

 
Eevhie - June 1, 2022

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

 
Eevhie - May 10, 2022

Lucid-MS for Multiple Sclerosis Treatment

<< View Post To Watch Video >>
Eevhie - May 1, 2022

"Julia Levy Award" Recipient David Allan and Dr. John McGraw

 
Eevhie - April 24, 2022